Consultation
Dr. Francis reviews your medication history and discusses whether GeneSight testing is appropriate for your treatment goals.
GeneSight Genetic Testing for Smarter Medication Choices in Weston, FL
Take the guesswork out of psychiatric prescribing with DNA-guided medication insights.
Test Type:Cheek swab (non-invasive)
Results:3-5 business days
FDA Cleared:Yes — pharmacogenomic platform
Coverage:Most insurance plans accepted
Why Finding the Right Psychiatric Medication Is So Difficult
Understanding Medication Response Variability
For many patients, finding the right psychiatric medication feels like an exhausting process of trial and error. Studies show that nearly two-thirds of patients with depression do not respond adequately to their first prescribed antidepressant. Each failed medication trial means weeks or months of waiting, lingering symptoms, and the emotional toll of feeling stuck. Genetic differences in how your body metabolizes and responds to medications are a major reason why a drug that works well for one person may be ineffective or cause significant side effects for another.
GeneSight genetic testing helps break this cycle by providing Dr. Francis with a science-backed report showing how your genes may influence your response to over 60 FDA-approved psychiatric medications. Rather than relying solely on clinical observation and standard dosing guidelines, Dr. Francis can use your genetic profile to make more informed prescribing decisions from the start. This precision-medicine approach reduces unnecessary medication switches, minimizes side effects, and helps you feel better sooner with a treatment plan tailored to your unique biology.
What Is GeneSight Genetic Testing?
The Science of Pharmacogenomics
GeneSight is the most widely used pharmacogenomic test in psychiatry, developed by Myriad Genetics. It analyzes clinically relevant genetic variations — known as pharmacogenomic markers — that influence how your body processes and responds to psychiatric medications, including antidepressants, antipsychotics, mood stabilizers, and ADHD medications. The test is FDA-cleared as a pharmacogenomic platform and has been validated in multiple clinical studies.
The science behind GeneSight centers on two key areas: pharmacokinetic genes that control how quickly your liver enzymes (such as CYP2D6 and CYP2C19) metabolize medications, and pharmacodynamic genes that influence how your brain receptors respond to those medications. Patients who are "poor metabolizers" may experience more side effects at standard doses, while "ultra-rapid metabolizers" may not achieve therapeutic levels. A landmark 2019 study in the American Journal of Psychiatry demonstrated that GeneSight-guided treatment led to a 50% greater improvement in depression symptoms compared to treatment as usual.
Treatment Timeline
Test Duration
Simple cheek swab — under 2 minutes
Results Available
3-5 business days after sample receipt
Report Review
30-minute consultation with Dr. Francis
Medication Adjustment
Same day as report review if indicated
Benefits of GeneSight Testing
Science-Backed Medication Clarity
- 01
Reduced Trial and Error
Fewer medication switches by identifying likely effective options from the start
- 02
Fewer Side Effects
Avoid medications your body may metabolize too slowly or too quickly
- 03
Faster Symptom Relief
Patients on guided treatment showed 50% greater improvement in depression
- 04
Non-Invasive Testing
Simple cheek swab performed in-office with no blood draw required
- 05
Covers 60+ Medications
Comprehensive analysis across antidepressants, antipsychotics, and more
GeneSight vs. Other Approaches
Compare Your Options
| Approach | Mechanism | Time to Results | Medication Coverage | Accuracy | Invasiveness | Best For |
|---|---|---|---|---|---|---|
| GeneSight Testing | Pharmacogenomic DNA analysis | 3-5 days | 60+ psychiatric medications | Clinically validated | Non-invasive cheek swab | Patients who have not responded to prior medications |
| Standard Pharmacogenomic Testing | Generic gene panel analysis | 5-10 days | Varies by panel | Variable validation | Cheek swab or blood draw | General pharmacogenomic screening |
| Trial-and-Error Prescribing | Clinical observation only | Weeks to months per trial | All medications | Based on clinical judgment | N/A | First-time medication patients with no prior failures |
Who Is a Good Candidate for GeneSight Testing?
Personalized Assessment Criteria
GeneSight genetic testing is especially valuable for patients who have experienced challenges with psychiatric medications, though it can also benefit those just beginning treatment who want a more informed starting point.
Ideal Candidates for GeneSight Testing
- Adults who have tried two or more psychiatric medications without adequate response
- Patients who have experienced significant side effects from standard-dose medications
- Individuals beginning psychiatric medication for the first time who want data-driven guidance
- Patients taking multiple medications who need to understand potential drug-gene interactions
- Anyone with a family history of poor medication response or unusual side effects
Who Should Wait or Avoid GeneSight Testing
- Patients who are currently stable and responding well to their current medication regimen
- Individuals seeking a test that diagnoses psychiatric conditions (GeneSight guides medication selection, not diagnosis)
- Patients expecting the test to identify a single "perfect" medication (results inform clinical decision-making alongside other factors)
GeneSight is a clinical decision-support tool — not a standalone diagnostic. Dr. Francis interprets your results alongside your medical history, current symptoms, and treatment goals to make the most informed prescribing recommendation.
How GeneSight Testing Works
Cheek Swab
A gentle cheek swab collects your DNA sample in under two minutes — no needles, no blood draw, no discomfort.
Lab Analysis
Your sample is sent to the Myriad Genetics CLIA-certified lab for comprehensive pharmacogenomic analysis.
Report Review
Dr. Francis reviews your personalized GeneSight report with you, explaining which medications may work best for your genetic profile.
Treatment Plan
Based on your results, Dr. Francis adjusts or initiates your medication plan for a more targeted, effective approach.
Safety and Considerations
What You Should Know
GeneSight testing is a non-invasive cheek swab with no physical side effects or risks from the test itself. There is no pain, no blood draw, and no recovery period required.
Important Considerations
While GeneSight provides valuable genetic insights, it is important to understand the scope of the test:
- GeneSight is a clinical decision-support tool, not a diagnostic test — it does not diagnose any psychiatric condition
- Results inform medication selection but do not guarantee a specific medication will work
- Environmental factors, lifestyle, other medications, and medical conditions also influence drug response
- Medication changes based on GeneSight results should always be made gradually and under Dr. Francis's supervision
- If a medication change is recommended, standard psychiatric monitoring applies during the transition period
Data Privacy
Your genetic information is protected under the Genetic Information Nondiscrimination Act (GINA) and Myriad Genetics' strict privacy policies. Your results are shared only with your ordering clinician and are not accessible to employers or health insurers for coverage or employment decisions.
GeneSight Testing Cost in Weston
Transparent Pricing and Insurance Options
At Refresh TMS, we believe that precision psychiatry should be accessible. GeneSight testing is covered by most major insurance plans, including Medicare and Medicaid in many states.
Insurance Coverage
Most patients with commercial insurance, Medicare, or Medicaid pay little to no out-of-pocket cost for GeneSight testing. Myriad Genetics works directly with your insurance provider to determine coverage and handle prior authorization when required.
Out-of-Pocket Maximum
For patients without insurance or with plans that do not cover pharmacogenomic testing, Myriad Genetics offers a patient assistance program with a maximum out-of-pocket cost of $330. Many patients qualify for reduced pricing based on financial need.
What Is Included
- In-office cheek swab collection
- Comprehensive pharmacogenomic analysis of 60+ medications
- Detailed clinician-guided report with medication categories
- Dedicated report review consultation with Dr. Francis
- Updated medication treatment plan based on results
To verify your coverage and learn about your specific costs, contact our office at (754) 216-0840 or email psychclinic@refreshtms.com. Our team will confirm your benefits before scheduling your test.
Why Choose Refresh TMS for GeneSight
Weston's Trusted Psychiatrist
Expert Interpretation
Board-certified psychiatrist who integrates genetic data with clinical insight
Comprehensive Care
GeneSight results combined with TMS, medication management, and therapy
Personalized Approach
Every report is reviewed in a dedicated consultation tailored to your needs
Ongoing Support
Continued follow-up to monitor medication response and adjust as needed
Related Services
Complementary Treatments
Psychiatry & Therapy
Brain & Mental Health
Wellness & Body Optimization
GeneSight Testing FAQ
Answers to Your Questions
01 What is GeneSight testing?
GeneSight is a pharmacogenomic test that uses a simple cheek swab to analyze how your genes may affect your response to over 60 FDA-approved psychiatric medications, including antidepressants, antipsychotics, mood stabilizers, and ADHD medications.
02 How long does the GeneSight test take?
The cheek swab itself takes less than two minutes. Results are typically available within 3-5 business days after the lab receives your sample.
03 Does GeneSight testing hurt?
Not at all. GeneSight requires only a gentle cheek swab — no needles, no blood draw. The collection is painless and performed in-office during your appointment.
04 Will GeneSight tell me exactly which medication to take?
GeneSight categorizes medications into three groups based on your genetic profile: use as directed, moderate gene-drug interaction, and significant gene-drug interaction. Dr. Francis uses these results alongside your clinical history to recommend the best medication for you.
05 Is GeneSight covered by insurance?
Yes, GeneSight is covered by most commercial insurance plans, Medicare, and many Medicaid plans. For uninsured patients, Myriad Genetics offers a maximum out-of-pocket cost of $330 with financial assistance available.
06 How is GeneSight different from other genetic tests?
GeneSight is the most studied and widely used pharmacogenomic test in psychiatry, backed by multiple peer-reviewed clinical trials. It specifically focuses on psychiatric medications and is supported by a dedicated clinical pharmacist team.
07 Do I need to stop my current medications before the test?
No. GeneSight analyzes your DNA, which does not change based on what medications you are currently taking. You can continue all prescribed medications as directed.
08 How soon will I feel better after getting my GeneSight results?
If a medication change is recommended based on your results, most patients begin to notice improvement within 4-12 weeks. The timeline depends on the specific medication prescribed and your individual response.
Location17110 Royal Palm Blvd, Suite 1
Weston, FL, 33326
Weston, FL, 33326
Phone(754) 216-0840
Schedule Your Genetic Testing (GeneSight) Consultation
References
- Greden JF, Parikh SV, Rothschild AJ, et al. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, multi-site, randomized, double-blind, controlled clinical trial. J Psychiatr Res. 2019;111:59-67. PubMed (PMID: 30677646) - GeneSight-guided care led to statistically significant improvement in depression response and remission rates versus treatment as usual.
- Hall-Flavin DK, Winner JG, Allen JD, et al. Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting. Pharmacogenet Genomics. 2013;23(10):535-548. PubMed (PMID: 24018772) - Patients whose treatment was guided by pharmacogenomic testing showed significantly greater improvement in depressive symptoms.
- Winner JG, Carhart JM, Altar CA, et al. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1-year prospective evaluation. Curr Med Res Opin. 2015;31(9):1633-1643. PubMed (PMID: 26086890) - GeneSight-guided prescribing was associated with a 28% reduction in total pharmacy costs over 12 months.
- Altar CA, Carhart JM, Allen JD, et al. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes. Pharmacogenomics J. 2015;15(5):443-451. PubMed (PMID: 25686762) - Multi-gene combinatorial analysis outperformed single-gene testing in predicting antidepressant outcomes.
- Bousman CA, Arandjelovic K, Mancuso SG, et al. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics. 2019;20(1):37-47. PubMed (PMID: 30520364) - Meta-analysis of pharmacogenomic-guided treatment demonstrated significantly higher remission rates in depression compared to standard care.